KEVIN KING: Open Payments
NPI 1528464070 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 20 payments from 7 companies in 2025. Trend: 2023 $328 · 2024 $188 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $172 |
| Exact Sciences Corporation | 4 | $96 |
| Lilly USA, LLC | 3 | $68 |
| Novo Nordisk Inc | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Renalytix AI, Inc. | 1 | $17 |
Products named: TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, MOUNJARO, Auvelity, SHINGRIX, Wegovy, BREZTRI, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across NY — which companies pay providers there.
